Edition:
United States

Albemarle Corp (ALB)

ALB on New York Consolidated

134.29USD
22 Sep 2017
Change (% chg)

$-0.60 (-0.44%)
Prev Close
$134.89
Open
$134.40
Day's High
$134.88
Day's Low
$133.26
Volume
1,324,237
Avg. Vol
1,307,299
52-wk High
$136.95
52-wk Low
$76.32

Chart for

About

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performanc... (more)

Overall

Beta: 1.65
Market Cap(Mil.): $14,835.38
Shares Outstanding(Mil.): 110.47
Dividend: 0.32
Yield (%): 0.95

Financials

  Industry Sector
P/E (TTM): -- 18.11 16.08
EPS (TTM): -- -- --
ROI: -- 19.57 14.60
ROE: -- 28.64 14.03

Albemarle asks Chile to raise lithium production limit

SANTIAGO, Sept 15 Albemarle Corp has asked Chile to increase the U.S. miner's lithium production limit in the country, it said on Friday, amid high global prices for the mineral used in batteries as demand for electric vehicles surges.

Sep 15 2017

BRIEF-Albemarle Q2 earnings per share $0.92

* Albemarle growth story continues with strong second quarter performance

Aug 07 2017

Lithium processors prepare to meet demand in era of electric car

LONDON Producers of processed lithium - an essential element for batteries used in electric cars - are agreeing long-term contracts with their customers to fund the investments needed to address a looming shortfall.

Aug 07 2017

BRIEF-Laurie Brlas gets elected to Albemarle board of directors

* Laurie Brlas elected to Albemarle Corporation board of directors

Jun 26 2017

Bayer CropScience lawsuit over 'bad faith' Albemarle pricing is revived

A federal appeals court on Tuesday said Bayer CropScience LP may pursue part of its lawsuit accusing Albemarle Corp of breach-of-contract and bad faith by imposing steep price increases on methyl bromide as the companies were preparing to sever their 16-year sales agreement.

Jun 20 2017

BRIEF-Albemarle reports Q1 sales $722.1 million

* Albemarle reports 10% growth in first quarter 2017 net sales

May 03 2017

Earnings vs. Estimates